Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (40 quarters reported)
$135M in Q4 2014 → $66.8M now. Hover for any quarter.
As reported for the quarter ended September 30, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| BH Berkshire Hathaway Inc Del | 100.0% | Trimmed 18% | 145,181 | $66.8M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2024 · filed November 13, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BH Berkshire Hathaway Inc Del | Trimmed | −32,600 | −$15M | 100.0% |
quarter ended June 30, 2024 · filed August 13, 2024
No position changes this quarter.
quarter ended March 31, 2024 · filed May 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BH Berkshire Hathaway Inc Del | Trimmed | −61,250 | −$25.8M | 100.0% |
| Spyre Therapeutics Inc | Exited | −577,616 | −$12.4M | — |
quarter ended December 31, 2023 · filed February 13, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Spyre Therapeutics Inc | New | +577,616 | +$12.4M | 12.7% |
quarter ended September 30, 2023 · filed November 13, 2023
No position changes this quarter.
quarter ended June 30, 2023 · filed August 11, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BH Berkshire Hathaway Inc Del | Trimmed | −77,211 | −$26.3M | 100.0% |
quarter ended March 31, 2023 · filed May 15, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BH Berkshire Hathaway Inc Del | Trimmed | −48,115 | −$14.9M | 100.0% |
quarter ended December 31, 2022 · filed February 13, 2023
No position changes this quarter.
Loading...
